[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100315162":3},{"organization":4,"armGroups":7,"interventions":30,"overallOfficials":51,"centralContacts":51,"locations":52,"responsibleParty":76,"collaborators":51,"id":79,"slug":80,"hasResults":81,"nctId":82,"briefTitle":83,"officialTitle":84,"acronym":51,"eligibilityCriteria":85,"healthyVolunteers":81,"sex":86,"minAge":87,"maxAge":88,"enrollmentInfo":89,"targetDuration":51,"studyType":92,"phases":93,"briefSummary":95,"conditions":96,"keywords":98,"overallStatus":55,"whyStopped":51,"lastUpdateSubmitDate":103,"lastUpdatePostDateStruct":104,"startDateStruct":107,"completionDateStruct":109,"leadSponsor":111,"locationsCount":112},{"fullName":5,"class":6},"Attikon Hospital","OTHER",[8,14,19,24],{"label":9,"type":10,"description":11,"interventionNames":12},"Dexmedetomidine","ACTIVE_COMPARATOR","Drug: dexmedetomidine (Dexmed) 20 mL solution of dexmedetomidine used for wound infiltration",[13],"Drug: Dexmedetomidine",{"label":15,"type":10,"description":16,"interventionNames":17},"Ropivacaine","Drug: ropivacaine 20 mL solution of ropivacaine 0.375% used for wound infiltration",[18],"Drug: Ropivacaine",{"label":20,"type":10,"description":21,"interventionNames":22},"Dexmedetomidine - Ropivacaine","Drug: dexmedetomidine (Dexmed) combined with Drug: ropivacaine 20 mL solution of dexmedetomidine 1γ\u002Fkg within ropivacaine 0.375% used for wound infiltration",[23],"Drug: Dexmedetomidine - Ropivacaine",{"label":25,"type":26,"description":27,"interventionNames":28},"0.9 % saline","PLACEBO_COMPARATOR","Drug:0.9 % saline solution (Normal saline). 20 ml with 0.9 % saline solution used for wound infiltration",[29],"Other: 0,9% saline",[31,37,41,45],{"type":32,"name":9,"description":33,"armGroupLabels":34,"otherNames":35},"DRUG","WOUND INFILTRATION IN CESAREAN SECTION",[9],[36],"Dexmed",{"type":32,"name":15,"description":33,"armGroupLabels":38,"otherNames":39},[15],[40],"Ropi",{"type":32,"name":20,"description":33,"armGroupLabels":42,"otherNames":43},[20],[44],"Dexmed Ropi",{"type":6,"name":46,"description":47,"armGroupLabels":48,"otherNames":49},"0,9% saline","placebo WOUND INFILTRATION IN CESAREAN SECTION",[25],[50],"normal saline",null,[53],{"facility":54,"status":55,"city":56,"state":57,"zip":58,"country":59,"countryCode":60,"cosmosGeoPoint":61,"geoPoint":66,"contacts":67},"Paraskevi K Matsota","RECRUITING","Athens","Other","13231","Greece","GR",{"type":62,"coordinates":63},"Point",[64,65],23.72784,37.98376,{"lat":65,"lon":64},[68,73],{"name":69,"role":70,"phone":71,"phoneExt":51,"email":72},"Paraskevi K Matsota, Assoc Prof","CONTACT","00306945544563","matsota@yahoo.gr",{"name":74,"role":75,"phone":51,"phoneExt":51,"email":51},"Paraskevi Mastota, MD, PhD","PRINCIPAL_INVESTIGATOR",{"type":75,"investigatorFullName":77,"investigatorTitle":78,"investigatorAffiliation":5,"oldNameTitle":51,"oldOrganization":51},"Paraskevi Matsota","Assoc Prof of Anaesthesiology","100315162","dexmedetomidine-wound-infiltration-in-cesarean-section-100315162",false,"NCT03382938","Dexmedetomidine Wound Infiltration in Cesarean Section","Wound Infiltration With Dexmedetomidine in Cesarean Section: Effect on Postoperative Analgesia","Inclusion Criteria:\n\n* pregnancy \\>37 weeks, ASA I-II, BMI\\\u003C35\n\nExclusion Criteria:\n\n* patient refusal, epilepsy, GERD, morbid obesity, drug allergy, ASA class \\>2, presence of atrioventricular block, severe systemic disease, multiple gestation, high risk pregnancy, contraindications to epidural technique, a history of severe systemic disease, recreational drug or alcohol use","FEMALE","18 Years","40 Years",{"count":90,"type":91},100,"ESTIMATED","INTERVENTIONAL",[94],"NA","The effects of four different wound infiltration protocols in cesarean section will be investigated on parturient' pain intensity, PCA morphine consumption given, side effects and parturient' overall satisfaction.\n\nOne group will receive for wound infiltration dexmedetomidine, the second ropivacaine, the third dexmedetomidine combined with ropivacaine, while the last one will receive normal saline (placebo group).",[97],"Postoperative Pain",[99,100,101,102],"dexmedetomidine","ropivacaine","wound infiltration","ceasarean section","2025-03-16",{"date":105,"type":106},"2025-03-19","ACTUAL",{"date":108,"type":106},"2019-08-23",{"date":110,"type":91},"2026-11-20",{"name":5,"class":6},1]